Literature DB >> 28093811

Routine Use of Distal Arterial Perfusion in Pediatric Femoral Venoarterial Extracorporeal Membrane Oxygenation.

Christine A Schad1, Brian P Fallon2, Julie Monteagudo1, Shunpei Okochi1, Eva W Cheung3, Nicholas J Morrissey4, Angela V Kadenhe-Chiweshe1, Gudrun Aspelund1, Steven Stylianos1, William Middlesworth1.   

Abstract

Lower-extremity ischemia is a significant complication in children on femoral venoarterial extracorporeal membrane oxygenation (VA ECMO). Our institution currently routinely uses distal perfusion catheters (DPCs) in all femoral arterial cannulations in attempts to reduce ischemia. We performed a single-center, retrospective review of pediatric patients supported with femoral VA ECMO from January 2005 to November 2015. The outcomes of patients with prophylactic DPC placement at cannulation (prophylactic DPC) were compared to a historical group with DPCs placed in response only to clinically evident ischemic changes (reactive DPC). Ischemic complication requiring invasive intervention (fasciotomy or amputation) was the primary outcome. Twenty-nine patients underwent a total of 31 femoral arterial cannulations, 17 with prophylactic DPC and 14 with reactive DPC. Ischemic complications requiring invasive intervention developed in 2 of 17 (12%) prophylactic DPC patients versus 4 of 14 (29%) reactive DPC. In the reactive DPC group, 7 of 14 (50%) had ischemic changes postcannulation, six underwent DPC placement, and three out of six of these patients still required invasive intervention. One of the seven patients had ischemic changes, did not undergo DPC, and required amputation. While a greater percentage of patients in the prophylactic group was cannulated during extracorporeal cardiopulmonary resuscitation (ECPR), statistical significance was not otherwise demonstrated. We demonstrate feasibility of superficial femoral artery (SFA) access in pediatric patients. We note fewer ischemic complications with prophylactic DPC placement, and observe that salvaging a limb with a reactive DPC was only successful 50% of the time. Although there was no statistical difference in the primary outcome between the two groups, limitations and confounding factors include small sample size and a greater percentage of patients in the prophylactic DPC group cannulated with ECPR in progress.
© 2017 International Center for Artificial Organs and Transplantation and Wiley Periodicals, Inc.

Entities:  

Keywords:  -Extracorporeal membrane oxygenation; -Femoral artery cannulation; -Pediatric; -distal perfusion; Limb ischemia

Mesh:

Year:  2017        PMID: 28093811     DOI: 10.1111/aor.12861

Source DB:  PubMed          Journal:  Artif Organs        ISSN: 0160-564X            Impact factor:   3.094


  5 in total

1.  Comparing Percutaneous to Open Access for Extracorporeal Membrane Oxygenation in Pediatric Respiratory Failure.

Authors:  Sarah B Cairo; Mary Arbuthnot; Laura Boomer; Michael W Dingeldein; Alexander Feliz; Samir Gadepalli; Christopher R Newton; Pramod Puligandla; Robert Ricca; Peter Rycus; Adam M Vogel; Guan Yu; Ziqiang Chen; David H Rothstein
Journal:  Pediatr Crit Care Med       Date:  2018-10       Impact factor: 3.624

Review 2.  Extracorporeal Membrane Oxygenation (ECMO) and the Critical Cardiac Patient.

Authors:  David A Baran
Journal:  Curr Transplant Rep       Date:  2017-07-10

3.  Risk factors for severe lower extremity ischemia following venoarterial extracorporeal membrane oxygenation: an analysis using a nationwide inpatient database.

Authors:  Akira Honda; Nobuaki Michihata; Yoichi Iizuka; Kazuaki Uda; Kojiro Morita; Tokue Mieda; Eiji Takasawa; Sho Ishiwata; Tsuyoshi Tajika; Hiroki Matsui; Kiyohide Fushimi; Hideo Yasunaga; Hirotaka Chikuda
Journal:  Trauma Surg Acute Care Open       Date:  2022-04-13

4.  Limb Ischemia Complications of Veno-Arterial Extracorporeal Membrane Oxygenation.

Authors:  Sixiong Hu; Andong Lu; Chenliang Pan; Bo Zhang; Yong Ling Wa; Wenjing Qu; Ming Bai
Journal:  Front Med (Lausanne)       Date:  2022-07-15

Review 5.  Pediatric and neonatal extracorporeal life support: current state and continuing evolution.

Authors:  Brian P Fallon; Samir K Gadepalli; Ronald B Hirschl
Journal:  Pediatr Surg Int       Date:  2021-01-01       Impact factor: 1.827

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.